Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-IR) inhibitors via hierarchical virtual screening

  • Xiaofeng Liu
  • , Hua Xie
  • , Cheng Luo
  • , Linjiang Tong
  • , Yi Wang
  • , Ting Peng
  • , Jian Ding
  • , Hualiang Jiang
  • , Honglin Li*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

Insulin-like growth factor-1 receptor (IGF-IR) is a growth factor receptor tyrosine kinase acting as a critical mediator of cell proliferation and survival. Novel 5-benzylidenethiazolidine-2,4-dione (5) and 5-(furan-2- ylmethylene)thiazolidine-2,4-dione (6) compounds were identified as potent and selective IGF-IR inhibitors via hierarchical virtual screening. Initial SAR and biological activity of the analogues of 5 and 6 with thiazolidine-2,4-dione template are presented, and several inhibitors with low nanomolar potency are reported.

Original languageEnglish
Pages (from-to)2661-2665
Number of pages5
JournalJournal of Medicinal Chemistry
Volume53
Issue number6
DOIs
StatePublished - 25 Mar 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-IR) inhibitors via hierarchical virtual screening'. Together they form a unique fingerprint.

Cite this